Traynor Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,744
| Closed | -$768K | – | 184 |
|
|
2019
Q3 | $768K | Sell |
7,744
-1,454
| -16% | -$138K | 0.24% | 76 |
|
|
2019
Q2 | $859K | Sell |
9,198
-4,492
| -33% | -$427K | 0.28% | 70 |
|
|
2019
Q1 | $1.29M | Sell |
13,690
-8,893
| -39% | -$778K | 0.43% | 46 |
|
|
2018
Q4 | $1.45M | Buy |
22,583
+4,772
| +27% | +$352K | 0.6% | 34 |
|
|
2018
Q3 | $1.59M | Buy |
17,811
+1,738
| +11% | +$154K | 0.52% | 38 |
|
|
2018
Q2 | $1.28M | Sell |
16,073
-1,301
| -7% | -$108K | 0.47% | 37 |
|
|
2018
Q1 | $1.55M | Buy |
17,374
+548
| +3% | +$52.6K | 0.63% | 32 |
|
|
2017
Q4 | $1.75M | Buy |
16,826
+2,278
| +16% | +$257K | 0.75% | 31 |
|
|
2017
Q3 | $2.08M | Buy |
14,548
+344
| +2% | +$46.9K | 0.99% | 24 |
|
|
2017
Q2 | $1.9M | Buy |
14,204
+1,209
| +9% | +$148K | 0.94% | 21 |
|
|
2017
Q1 | $1.61M | Buy |
12,995
+1,206
| +10% | +$144K | 0.9% | 24 |
|
|
2016
Q4 | $1.33M | Sell |
11,789
-600
| -5% | -$66.8K | 0.88% | 27 |
|
|
2016
Q3 | $1.24M | Buy |
12,389
+131
| +1% | +$14.2K | 0.88% | 29 |
|
|
2016
Q2 | $1.23M | Sell |
12,258
-490
| -4% | -$50.7K | 0.96% | 26 |
|
|
2016
Q1 | $1.27M | Sell |
12,748
-1,870
| -13% | -$193K | 1.02% | 25 |
|
|
2015
Q4 | $1.75M | Buy |
14,618
+1,435
| +11% | +$166K | 1.26% | 21 |
|
|
2015
Q3 | $1.43M | Buy |
13,183
+579
| +5% | +$71.9K | 1.23% | 18 |
|
|
2015
Q2 | $1.46M | Sell |
12,604
-210
| -2% | -$24K | 1.22% | 16 |
|
|
2015
Q1 | $1.48M | Buy |
12,814
+1,720
| +16% | +$206K | 1.42% | 12 |
|
|
2014
Q4 | $1.24M | Buy |
+11,094
| New | +$1.17M | 1.44% | 13 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Traynor Capital Management's CELG Position: Q4 2019 in Review
Traynor Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,744 shares — an estimated $768K sold.
Traynor Capital Management first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $2.08M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Traynor Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Traynor Capital Management sold 7,744 Celgene Corp shares in Q4 2019, an estimated $768K.
- Traynor Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
- Traynor Capital Management's Celgene Corp position peaked at $2.08M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Traynor Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.